Developing Tools For Reliable Gene Chip Measurements

SPACE MEDICINE

illustration only

Washington - May 25, 2004
Microarrays, sometimes called "gene chip" devices, enable researchers to monitor the activities of thousands of genes from a single tissue sample simultaneously, identifying patterns that may be novel indicators of disease status. But generating consistent, verifiable results is difficult because of a lack of standards to validate these analyses, scientists from the National Institute of Standards and Technology (NIST) and collaborators warn in the May 20 online issue of Clinical Chemistry.

Microarrays are keychain-sized devices with as many as several million tiny spots, each of which examines genes of interest simultaneously using minute sample volumes. This highly sensitive technology is relatively new, and standard procedures to ensure the reliability and comparability of results are only beginning to emerge.

For instance, results can change as a result of differences in how tissues are collected and processed; variations in how the molecules are counted, attached to substrates and labeled for detection; deviations from recommended protocols by lab personnel; and malfunctioning or miscalibrated equipment. Such variations need to be controlled before this technology can be used reliably in clinical settings and in devices requiring regulatory approval, according to the paper.

As a first step toward addressing reliability issues, a consortium co-led by NIST and industry is developing standards that will satisfy needs identified at a 2003 workshop. At the workshop, organized and hosted by NIST, leaders in the microarray field from industry, government and universities recommended the development of a well-characterized set of ribonucleic acid (RNA) molecules whose identity and concentration are known. RNA is an important product of gene activity.

Users will be able to validate the results of gene chip analyses by adding such a reference material to their samples and comparing the measured values to what would be expected for them. Such a reference material also will enable technology developers and researchers to assess the performance of their assays.

SPACE MEDICINE

Expanding The Genetic Code

San Diego CA (SPX) May 25, 2004
A team of investigators at The Scripps Research Institute and its Skaggs Institute for Chemical Biology in La Jolla, California has modified a form of the bacterium Escherichia coli to use a 22-amino acid genetic code.

SUPERPOWERS US Warned Not To Ignore Chinese Military Advances	NUKEWARS US Nuclear Strategy Hits Congress DOE Nuclear Security Plan Questioned New Detectors Can Nail Smuggled Nukes GAO Questions U.S. Nuclear Security
MISSILE NEWS Lockheed Martin Conducts Successful Guided MLRS Unitary Rocket Test Raytheon To Supply Ship Self-Defense Systems Computing Platform NATO Moves Ahead On MEADS Development Orbital Flight Tests Supersonic Sea-Skimming Target Missile	MISSILE DEFENSE Lockheed Martin Offeres Two Open Architecture Capabilities For Aegis Missile Defense On Alert By September URS Wins Navy Contract For Missile Defense Theater Managament Lockheed Martin Demonstrates Open Architecture for Aegis Weapon System
AEROSPACE Sonic Boom Modification May Lead To New Era Hewitt Pledges Support For Aerospace Industry National Consortium Picks Aviation Technology Test Site Wright Flyer Takes To The Sky In Las Vegas	UAV NEWS Brain-based Control For Unmanned Vehicles United Industrial Training Soldiers To Use Raven UAV System Raytheon Integrates and Tests SeaVue Radar and MTS Onboard Predator B Navy Demonstrates Future Warfare Strategy
IRAQ WARS	MILTECH Airbag Inflators Provide Push For New Surface Vessel Launcher Russian Navy May Sink By 2008: Admiral

The content herein, unless otherwise known to be public domain, are Copyright 1995-2006 - SpaceDaily.AFP and UPI Wire Stories are copyright Agence France-Presse and United Press International. ESA PortalReports are copyright European Space Agency. All NASA sourced material is public domain. Additionalcopyrights may apply in whole or part to other bona fide parties. Advertising does not imply endorsement,agreement or approval of any opinions, statements or information provided by SpaceDaily on any Web page published or hosted by SpaceDaily. Privacy Statement